{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:32:56Z","timestamp":1792099976327,"version":"4.4.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","journal-cot.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Orthopaedics and Trauma"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.jcot.2018.08.019","type":"journal-article","created":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T18:07:24Z","timestamp":1535047644000},"page":"49-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Innovative regenerative medicine in the management of knee OA: The role of Autologous Protein Solution"],"prefix":"10.1016","volume":"10","author":[{"given":"Nicol\u00f2 Danilo","family":"Vitale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Vandenbulcke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Chisari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Iacono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Lovato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berardo","family":"Di Matteo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizaveta","family":"Kon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jcot.2018.08.019_bib1","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.joca.2010.09.013","article-title":"OARSI-FDA initiative: defining the disease state of osteoarthritis","volume":"19","author":"Lane","year":"2011","journal-title":"Osteoarthritis Cartilage"},{"issue":"7","key":"10.1016\/j.jcot.2018.08.019_bib2","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nrrheum.2016.65","article-title":"Ageing and the pathogenesis of osteoarthritis","volume":"12","author":"Loeser","year":"2016","journal-title":"Nat Rev Rheumatol"},{"issue":"no. 1","key":"10.1016\/j.jcot.2018.08.019_bib3","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.bbapap.2011.06.020","article-title":"Proteases involved in cartilage matrix degradation in osteoarthritis","volume":"1824","author":"Troeberg","year":"2012","journal-title":"Biochim Biophys Acta Protein Proteonomics"},{"issue":"1","key":"10.1016\/j.jcot.2018.08.019_bib4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrrheum.2014.162","article-title":"Emerging regulators of the inflammatory process in osteoarthritis","volume":"11","author":"Liu-Bryan","year":"2015","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"10.1016\/j.jcot.2018.08.019_bib5","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1002\/art.34453","article-title":"Osteoarthritis: a disease of the joint as an organ","volume":"64","author":"Loeser","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.jcot.2018.08.019_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar3555","article-title":"Plasma proteins present in osteoarthritic synovial fluid can stimulate cytokine production via Toll-like receptor 4","volume":"14","author":"Sohn","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"10.1016\/j.jcot.2018.08.019_bib7","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1038\/nm.2543","article-title":"Identification of a central role for complement in osteoarthritis","volume":"17","author":"Wang","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.jcot.2018.08.019_bib8","unstructured":"M. De Santis, B. Di Matteo, et\u00a0al , \u201cThe Wnt pathway as a potential therapeutic target in osteoarthritis\u202f:,\u201d BioMed Res Int."},{"issue":"1","key":"10.1016\/j.jcot.2018.08.019_bib9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrrheum.2010.195","article-title":"Muscle weakness, afferent sensory dysfunction and exercise in knee osteoarthritis","volume":"7","author":"Roos","year":"2011","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"10.1016\/j.jcot.2018.08.019_bib10","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1007\/s00167-016-4125-y","article-title":"Regenerative approaches for the treatment of early OA","volume":"24","author":"de Girolamo","year":"2016","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"issue":"6","key":"10.1016\/j.jcot.2018.08.019_bib11","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1007\/s00167-016-4089-y","article-title":"Non-surgical treatments for the management of early osteoarthritis","volume":"24","author":"Filardo","year":"2016","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"issue":"10","key":"10.1016\/j.jcot.2018.08.019_bib12","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s00011-003-1197-1","article-title":"The production of anti-inflammatory cytokines in whole blood by physico-chemical induction","volume":"52","author":"Meijer","year":"2003","journal-title":"Inflamm Res"},{"issue":"2","key":"10.1016\/j.jcot.2018.08.019_bib13","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.joca.2008.06.014","article-title":"Autologous conditioned serum (Orthokine) is an effective treatment for knee osteoarthritis","volume":"17","author":"Baltzer","year":"2009","journal-title":"Osteoarthritis Cartilage"},{"issue":"3","key":"10.1016\/j.jcot.2018.08.019_bib14","doi-asserted-by":"crossref","DOI":"10.1186\/ar3050","article-title":"Cytokine profile of autologous conditioned serum for treatment of osteoarthritis, in\u00a0vitro effects on cartilage metabolism and intra-articular levels after injection","volume":"12","author":"Rutgers","year":"2010","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"10.1016\/j.jcot.2018.08.019_bib15","article-title":"Cultures of a human synovial cell line to evaluate platelet-rich plasma and hyaluronic acid effects","volume":"12","author":"Olivotto","year":"2018","journal-title":"J.\u00a0Tissue Eng. Regen. Med."},{"issue":"9","key":"10.1016\/j.jcot.2018.08.019_bib16","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1007\/s00167-013-2743-1","article-title":"Platelet-rich plasma: why intra-articular? A systematic review of preclinical studies and clinical evidence on PRP for joint degeneration","volume":"23","author":"Filardo","year":"2015","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"issue":"3","key":"10.1016\/j.jcot.2018.08.019_bib17","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1007\/s00167-015-3705-6","article-title":"Multiple PRP injections are more effective than single injections and hyaluronic acid in knees with early osteoarthritis: a randomized, double-blind, placebo-controlled trial","volume":"25","author":"G\u00f6rmeli","year":"2017","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"10.1016\/j.jcot.2018.08.019_bib18","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2147\/DDDT.S156724","article-title":"Intra-articular platelet-rich plasma versus hyaluronic acid in the treatment of knee osteoarthritis: a meta-analysis","volume":"12","author":"Zhang","year":"2018","journal-title":"Drug Des Dev Ther"},{"issue":"7","key":"10.1016\/j.jcot.2018.08.019_bib19","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1177\/0363546515582027","article-title":"Platelet-rich plasma intra-articular knee injections show no superiority versus viscosupplementation: a randomized controlled trial","volume":"43","author":"Filardo","year":"2015","journal-title":"Am J Sports Med"},{"issue":"1","key":"10.1016\/j.jcot.2018.08.019_bib20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40634-016-0043-7","article-title":"White blood cell concentration correlates with increased concentrations of IL-1ra and improvement in WOMAC pain scores in an open-label safety study of autologous protein solution","volume":"3","author":"King","year":"2016","journal-title":"J.\u00a0Exp. Orthop."},{"issue":"6","key":"10.1016\/j.jcot.2018.08.019_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156137","article-title":"Leukocyte-rich Platelet-rich Plasma injections do not up-modulate intra- articular pro-inflammatory cytokines in the osteoarthritic knee","volume":"11","author":"Mariani","year":"2016","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.jcot.2018.08.019_bib22","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1007\/s00167-014-3113-3","article-title":"\u201cEffect of two different preparations of platelet-rich plasma on synoviocytes,\u201d Knee Surgery","volume":"23","author":"Assirelli","year":"2015","journal-title":"Sport. Traumatol. Arthrosc."},{"issue":"5","key":"10.1016\/j.jcot.2018.08.019_bib23","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2106\/JBJS.M.00726","article-title":"Comparison of platelet-rich plasma formulations for cartilage healing: an in\u00a0vitro study","volume":"96","author":"Cavallo","year":"2014","journal-title":"J.\u00a0Bone Jt. Surg. - Ser. A"},{"issue":"10","key":"10.1016\/j.jcot.2018.08.019_bib24","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s00011-011-0353-2","article-title":"Blood-derived anti-inflammatory protein solution blocks the effect of IL-1\u03b2 on human macrophages in\u00a0vitro","volume":"60","author":"O'Shaughnessey","year":"2011","journal-title":"Inflamm Res"},{"issue":"12","key":"10.1016\/j.jcot.2018.08.019_bib25","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1002\/jor.22464","article-title":"Autologous solution protects bovine cartilage explants from IL-1??- and TNF??-induced cartilage degradation","volume":"31","author":"Matuska","year":"2013","journal-title":"J\u00a0Orthop Res"},{"issue":"9","key":"10.1016\/j.jcot.2018.08.019_bib26","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1002\/jor.21384","article-title":"Autologous protein solution inhibits MMP-13 production by IL-1\u03b2 and TNF\u03b1-stimulated human articular chondrocytes","volume":"29","author":"Woodell-May","year":"2011","journal-title":"J\u00a0Orthop Res"},{"issue":"2","key":"10.1016\/j.jcot.2018.08.019_bib27","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2460\/ajvr.75.2.141","article-title":"Evaluation of a single intra-articular injection of autologous protein solution for treatment of osteoarthritis in horses","volume":"75","author":"Bertone","year":"2014","journal-title":"Am J Vet Res"},{"issue":"10","key":"10.1016\/j.jcot.2018.08.019_bib28","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1002\/jor.22671","article-title":"Autologous protein solution prepared from the blood of osteoarthritic patients contains an enhanced profile of anti-inflammatory cytokines and anabolic growth factors","volume":"32","author":"O'Shaughnessey","year":"2014","journal-title":"J\u00a0Orthop Res"},{"issue":"5","key":"10.1016\/j.jcot.2018.08.019_bib29","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1177\/0363546514525593","article-title":"The effect of platelet-rich plasma formulations and blood products on human synoviocytes: implications for intra-articular injury and therapy","volume":"42","author":"Braun","year":"2014","journal-title":"Am J Sports Med"},{"issue":"9","key":"10.1016\/j.jcot.2018.08.019_bib30","doi-asserted-by":"crossref","first-page":"e211","DOI":"10.1038\/cddis.2011.94","article-title":"Microparticles from apoptotic platelets promote resident macrophage differentiation","volume":"2","author":"Vasina","year":"2011","journal-title":"Cell Death Dis"},{"issue":"3","key":"10.1016\/j.jcot.2018.08.019_bib31","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/jcp.22274","article-title":"Molecular basis of anti-inflammatory action of platelet-rich plasma on human chondrocytes: mechanisms of NF-\u03baB inhibition via HGF","volume":"225","author":"Bendinelli","year":"2010","journal-title":"J\u00a0Cell Physiol"},{"issue":"1","key":"10.1016\/j.jcot.2018.08.019_bib32","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1177\/0363546517732734","article-title":"Clinical outcomes of knee osteoarthritis treated with an autologous protein solution injection: a 1-year pilot double-blinded randomized controlled trial","volume":"46","author":"Kon","year":"2018","journal-title":"Am J Sports Med"},{"issue":"5","key":"10.1016\/j.jcot.2018.08.019_bib33","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.joca.2004.02.001","article-title":"OMERACT-OARSI Initiative: osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited","volume":"12","author":"Pham","year":"2004","journal-title":"Osteoarthritis Cartilage"}],"updated-by":[{"DOI":"10.1016\/j.jcot.2020.10.026","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000}},{"DOI":"10.1016\/j.jcot.2020.09.032","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000}},{"DOI":"10.1016\/j.jcot.2020.10.044","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000}}],"container-title":["Journal of Clinical Orthopaedics and Trauma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0976566218303965?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0976566218303965?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T04:36:20Z","timestamp":1548045380000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0976566218303965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0976566218303965"],"URL":"https:\/\/doi.org\/10.1016\/j.jcot.2018.08.019","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.jcot.2020.10.044","asserted-by":"object"},{"id-type":"doi","id":"10.1016\/j.jcot.2020.10.026","asserted-by":"object"},{"id-type":"doi","id":"10.1016\/j.jcot.2020.09.032","asserted-by":"object"}]},"ISSN":["0976-5662"],"issn-type":[{"value":"0976-5662","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Innovative regenerative medicine in the management of knee OA: The role of Autologous Protein Solution","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Orthopaedics and Trauma","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcot.2018.08.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018","name":"copyright","label":"Copyright"}]}}